File Download
 
 
Supplementary

Conference Paper: Profiles of HBV DNA, ALT, and HBeAg status after stopping lamivudine in patients with HBeAg seroconversion
  • Basic View
  • Metadata View
  • XML View
TitleProfiles of HBV DNA, ALT, and HBeAg status after stopping lamivudine in patients with HBeAg seroconversion
 
AuthorsFung, JYY
Lai, CL
Tanaka, Y
Mizokami, M
Yuen, JCH
Wong, DKH
Yuen, RMF
 
Issue Date2007
 
CitationThe 58th Annual Meeting of the American Association of the Study of Liver Diseases, Boston, USA, p. 989A [How to Cite?]
 
DC FieldValue
dc.contributor.authorFung, JYY
 
dc.contributor.authorLai, CL
 
dc.contributor.authorTanaka, Y
 
dc.contributor.authorMizokami, M
 
dc.contributor.authorYuen, JCH
 
dc.contributor.authorWong, DKH
 
dc.contributor.authorYuen, RMF
 
dc.date.accessioned2010-09-25T20:18:56Z
 
dc.date.available2010-09-25T20:18:56Z
 
dc.date.issued2007
 
dc.identifier.citationThe 58th Annual Meeting of the American Association of the Study of Liver Diseases, Boston, USA, p. 989A [How to Cite?]
 
dc.identifier.hkuros145544
 
dc.identifier.spage989
 
dc.identifier.urihttp://hdl.handle.net/10722/102147
 
dc.languageeng
 
dc.relation.ispartofThe 58th Annual Meeting of the American Association of the Study of Liver Diseases, Boston, USA
 
dc.titleProfiles of HBV DNA, ALT, and HBeAg status after stopping lamivudine in patients with HBeAg seroconversion
 
dc.typeConference_Paper
 
<?xml encoding="utf-8" version="1.0"?>
<item><contributor.author>Fung, JYY</contributor.author>
<contributor.author>Lai, CL</contributor.author>
<contributor.author>Tanaka, Y</contributor.author>
<contributor.author>Mizokami, M</contributor.author>
<contributor.author>Yuen, JCH</contributor.author>
<contributor.author>Wong, DKH</contributor.author>
<contributor.author>Yuen, RMF</contributor.author>
<date.accessioned>2010-09-25T20:18:56Z</date.accessioned>
<date.available>2010-09-25T20:18:56Z</date.available>
<date.issued>2007</date.issued>
<identifier.citation>The 58th Annual Meeting of the American Association of the Study of Liver Diseases, Boston, USA, p. 989A</identifier.citation>
<identifier.uri>http://hdl.handle.net/10722/102147</identifier.uri>
<language>eng</language>
<relation.ispartof>The 58th Annual Meeting of the American Association of the Study of Liver Diseases, Boston, USA</relation.ispartof>
<title>Profiles of HBV DNA, ALT, and HBeAg status after stopping lamivudine in patients with HBeAg seroconversion</title>
<type>Conference_Paper</type>
<identifier.hkuros>145544</identifier.hkuros>
<identifier.spage>989</identifier.spage>
</item>